Dr. Andy Salmon is a Clinician Scientist
Fellow, funded by the Medical Research Council and Academy of Medical Sciences.
His studies are based at the Universities of Bristol and Southern California. His research focuses on the process of glomerular filtration, mechanisms leading to altered
permeability in renal and systemic diseases and the manipulation of the cellular components of the glomerular filtration
barrier to modify albuminuria and the progression of kidney disease. Dr Salmon is currently researching the ability of the endothelial glycocalyx, and molecules that mediate cross-talk between glomerular capillary wall cells, to restore normal filtration in proteinuric kidney disease.
Dr.
Iván M. Moya is an Ecuadorian
biologist. He obtained his Licentiate
degree at the Catholic University in Quito, where he studied gastrulation
during early frog development. Afterwards, he was recruited as part of the VIB
international PhD program in Belgium and joined the laboratory of Prof. An Zwijzen
(KULeuven) to study the role of BMP/Smad signaling in angiogenesis. During his
PhD studies, Dr. Moya and coworkers discovered that BMP-Smad1/5 signaling is
integral to priming blood vessel plasticity, and that oscillatory interactions
between HES1 and Id proteins are crucial for the selection of tip and stalk
cells. In addition, Dr. Moya found that BMP-Smad1/5 signaling also regulates
cell polarity and migration of tip cells. Currently, Dr. Moya is working at the
VIB Center for the Biology of Disease in the laboratory of Prof. Georg Halder
(KULeuven) where he studies the role of the tumor suppressor Hippo pathway in
tumor development and cancer angiogenesis.
Dr. Pasquale Maffia - Dr. Maffia received his BSc(HONS) in Pharmacy in 1994, his MSc in Pharmacology in 1996 and his Ph.D. in Pharmacology in 2000 all from the University of Naples Federico II (Italy), where he became Aggregate Professor of Pharmacology in 2006. He joined the University of Strathclyde (UK) in 2007 as Lecturer in Integrative Mammalian Biology. He is currently Lecturer at the Institute of Infection, Immunity and Inflammation (University of Glasgow, UK). He is a British Pharmacological Society Meetings Committee member and editorial board member of Current Angiogenesis. Dr Maffia has authored over 40 scientific papers in peer-reviewed journals including Circulation, PNAS, Blood and Pharmacology & Therapeutics. Dr. Maffia long term research interest is the role of the immune-inflammatory response in cardiovascular diseases. Current research activities address the imaging and study of cellular and molecular mechanisms involved in the pathophysiology of atherosclerosis and neointimal formation.
Personal webpage:
http://www.gla.ac.uk/researchinstitutes/iii/staff/pasqualemaffia/#tabs=0
Dr. Pasquale Maffia - Dr. Maffia received his BSc(HONS) in Pharmacy in 1994, his MSc in Pharmacology in 1996 and his Ph.D. in Pharmacology in 2000 all from the University of Naples Federico II (Italy), where he became Aggregate Professor of Pharmacology in 2006. He joined the University of Strathclyde (UK) in 2007 as Lecturer in Integrative Mammalian Biology. He is currently Lecturer at the Institute of Infection, Immunity and Inflammation (University of Glasgow, UK). He is a British Pharmacological Society Meetings Committee member and editorial board member of Current Angiogenesis. Dr Maffia has authored over 40 scientific papers in peer-reviewed journals including Circulation, PNAS, Blood and Pharmacology & Therapeutics. Dr. Maffia long term research interest is the role of the immune-inflammatory response in cardiovascular diseases. Current research activities address the imaging and study of cellular and molecular mechanisms involved in the pathophysiology of atherosclerosis and neointimal formation.
Personal webpage:
http://www.gla.ac.uk/researchinstitutes/iii/staff/pasqualemaffia/#tabs=0